<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31951003</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1554-6578</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of neuropathology and experimental neurology</Title><ISOAbbreviation>J Neuropathol Exp Neurol</ISOAbbreviation></Journal><ArticleTitle>Neuropathology of Speech Network Distinguishes Bulbar From Nonbulbar Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>284</StartPage><EndPage>295</EndPage><MedlinePgn>284-295</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jnen/nlz130</ELocationID><Abstract><AbstractText>Bulbar amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative subtype affecting speech and swallowing motor functions as well as associated with the burden of cognitive deficits. The neuroanatomical underpinnings of bulbar ALS are not well understood. The aim of this study was to compare neuropathology of the speech network (SpN) between 3 cases of bulbar-onset ALS (bALS), 3 cases of spinal-onset ALS (sALS) with antemortem bulbar ALS (sALSwB) against 3 sALS without antemortem bulbar ALS (sALSnoB) and 3 controls. Regional distribution and severity of neuronal loss, TDP-43 (transactive response DNA-binding protein of 43&#x2009;kDa), and tau proteinopathy were examined. All 3 bALS cases showed marked neuronal loss and severe proteinopathy across most SpN regions; sALSwB cases showed no neuronal loss but mild and variable TDP-43 pathology in focal regions; sALSnoB cases demonstrated an absence of pathology. Two bALS cases had coexisting tauopathy in SpN regions, which was not noted in any sALS cases. The findings suggested that bALS may have a distinct neuropathological signature characterized by marked neuronal loss and polypathology in the SpN. Milder TDP-43 pathology in the SpN for sALSwB cases suggested a link between severity of bulbar ALS and SpN damage. Findings support a clinicopathologic link between bulbar symptoms and pathology in the SpN.</AbstractText><CopyrightInformation>&#xa9; 2019 American Association of Neuropathologists, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shellikeri</LastName><ForeName>Sanjana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Speech-Language Pathology &amp; Rehabilitation Sciences Institute, University of Toronto.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Program, Sunnybrook Research Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keith</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory Medicine and Molecular Diagnostics, Anatomic Pathology, Sunnybrook Health Sciences Centre, and Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Sandra E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Program, Sunnybrook Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>L.C. Campbell Cognitive Neurology Research Unit, Cognitive Neurology, Sunnybrook Research Institute, University of Toronto.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rotman Research Institute, Baycrest.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinman</LastName><ForeName>Lorne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Program, Sunnybrook Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>L.C. Campbell Cognitive Neurology Research Unit, Cognitive Neurology, Sunnybrook Research Institute, University of Toronto.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yunusova</LastName><ForeName>Yana</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Speech-Language Pathology &amp; Rehabilitation Sciences Institute, University of Toronto.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hurvitz Brain Sciences Program, Sunnybrook Research Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Health Network - Toronto Rehabilitation Institute (YY), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DC009890</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DC013547</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuropathol Exp Neurol</MedlineTA><NlmUniqueID>2985192R</NlmUniqueID><ISSNLinking>0022-3069</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C054369">MAPT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005911" MajorTopicYN="N">Gliosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013060" MajorTopicYN="N">Speech</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Bulbar</Keyword><Keyword MajorTopicYN="N">Frontotemporal lobar degeneration (FTLD)</Keyword><Keyword MajorTopicYN="N">Immunohistochemistry</Keyword><Keyword MajorTopicYN="N">Neuropathology</Keyword><Keyword MajorTopicYN="N">Speech network</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31951003</ArticleId><ArticleId IdType="pmc">PMC7036661</ArticleId><ArticleId IdType="doi">10.1093/jnen/nlz130</ArticleId><ArticleId IdType="pii">5708971</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Front Degener 2017;18:153&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Haverkamp LJ, Appel V, Appel SH.. Natural history of amyotrophic lateral sclerosis in a database population validation of a scoring system and a model for survival prediction. Brain 1995;118:707&#x2013;19</Citation><ArticleIdList><ArticleId IdType="pubmed">7600088</ArticleId></ArticleIdList></Reference><Reference><Citation>Raaphorst J, Visser MD, Linssen W, et al. The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis. Amyotroph Lateral Scler 2010;11:27&#x2013;37</Citation><ArticleIdList><ArticleId IdType="pubmed">19180349</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A, Iazzolino B, Calvo A, et al. Cognitive correlates in amyotrophic lateral sclerosis: A population-based study in Italy. J Neurol Neurosurg Psychiatry 2015;86:168&#x2013;73</Citation><ArticleIdList><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study. J Neurol Neurosurg Psychiatry 2012;83:102&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmore SE, Lehman ME.. Physiologic deficits in the orofacial system underlying dysarthria in amyotrophic lateral sclerosis. J Speech Lang Hear Res 1994;37:28&#x2013;37</Citation><ArticleIdList><ArticleId IdType="pubmed">8170127</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter RJ, McDonald TJ, Howard FM.. The otolaryngologic presentation of amyotrophic lateral sclerosis. Otolaryngology 1978;86:ORL479&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">112540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jablecki CK, Berry C, Leach J. Survival Prediction in Amyotrophic Lateral Sclerosis. Muscle Nerve 1989;12:833&#x2013;41</Citation><ArticleIdList><ArticleId IdType="pubmed">2608080</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris F, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">8229050</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: A randomised controlled trial. Lancet Neurol 2006;5:140&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">16426990</ArticleId></ArticleIdList></Reference><Reference><Citation>Worwood AM, Leigh PN.. Indicators and prevalence of malnutrition in motor neurone disease. Eur Neurol 1998;40:159.</Citation><ArticleIdList><ArticleId IdType="pubmed">9748674</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons Z, Stephens H, Felgoise S, et al. Examining the relationship of bulbar and limb function to patient reported quality of life: A multinational study. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:69</Citation></Reference><Reference><Citation>Watts CR, Vanryckeghem M.. Laryngeal dysfunction in amyotrophic lateral sclerosis: A review and case report. BMC Ear Nose Throat Disord 2001;1:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC60006</ArticleId><ArticleId IdType="pubmed">11722802</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorkston KM. The degenerative dysarthrias: A window into critical clinical and research issues. Folia Phoniatr Logop 2007;59:107&#x2013;17</Citation><ArticleIdList><ArticleId IdType="pubmed">17556854</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscaritoli M, Kushta I, Molfino A, et al. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. Nutrition 2012;28:959&#x2013;66</Citation><ArticleIdList><ArticleId IdType="pubmed">22677356</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterling LE, Jawaid A, Salamone AR, et al. Association between dysarthria and cognitive impairment in ALS: A prospective study. Amyotroph Lateral Scler 2010;11:46&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">19722114</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Goldstein LH, Pickering A, et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1997;62:464&#x2013;72</Citation><ArticleIdList><ArticleId IdType="pmc">PMC486852</ArticleId><ArticleId IdType="pubmed">9153602</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol 2005;252:772&#x2013;81</Citation><ArticleIdList><ArticleId IdType="pubmed">15742104</ArticleId></ArticleIdList></Reference><Reference><Citation>Bak TH, Chandran S.. What wires together dies together: Verbs, actions and neurodegeneration in motor neuron disease. Cortex 2012;48:936&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pubmed">21924711</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">21464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257&#x2013;68</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245&#x2013;56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellison D, Love S, Chimelli LMC, et al. Neuropathology E-Book: A Reference Text of CNS Pathology. Edinburgh, Scotland: Elsevier Health Sciences; 2012</Citation></Reference><Reference><Citation>Esiri M, Squier W, Perl D, Oppenheimer&#x2019;s Diagnostic Neuropathology: A Practical Manual. Boca Raton, FL: CRC Press; 2006</Citation></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (80-) 2006;314:130&#x2013;3</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602&#x2013;11</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince PG, Evans J, Knopp M, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003;60:1252&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">12707426</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Neumann M, Baborie A, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011;122:111&#x2013;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285143</ArticleId><ArticleId IdType="pubmed">21644037</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K, Hirai S, Yamazaki T, et al. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 1991;129:233&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">1660578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickok G. Functional anatomy of speech perception and speech production: Psycholinguistic implications. J Psycholinguist Res 2001;30:225&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">11523272</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagoort P, Levelt W.. The speaking brain. Science 2009;326:372&#x2013;3</Citation><ArticleIdList><ArticleId IdType="pubmed">19833945</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther FH, Ghosh SS, Tourville JA.. Neural modeling and imaging of the cortical interactions underlying syllable production. Brain Lang 2006;96:280&#x2013;301</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1473986</ArticleId><ArticleId IdType="pubmed">16040108</ArticleId></ArticleIdList></Reference><Reference><Citation>Golfinopoulos E, Tourville JA, Guenther FH.. The integration of large-scale neural network modeling and functional brain imaging in speech motor control. Neuroimage 2010;52:862&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2891349</ArticleId><ArticleId IdType="pubmed">19837177</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim S, Opitz B, M&#xfc;ller K, et al. Phonological processing during language production: fMRI evidence for a shared production-comprehension network. Brain Res Cogn Brain Res 2003;16:285&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">12668238</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim S, Opitz B, Friederici AD.. Distributed cortical networks for syntax processing: Broca&#x2019;s area as the common denominator. Brain Lang 2003;85:402&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">12744952</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitney C, Kirk M, O'Sullivan J, et al. The neural organization of semantic control: TMS evidence for a distributed network in left inferior frontal and posterior middle temporal gyrus. Cereb Cortex 2011;21:1066&#x2013;75</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3077429</ArticleId><ArticleId IdType="pubmed">20851853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau EF, Phillips C, Poeppel D.. A cortical network for semantics: (de)constructing the N400. Nat Rev Neurosci 2008;9:920.</Citation><ArticleIdList><ArticleId IdType="pubmed">19020511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gliebus G, Bigio EH, Gasho K, et al. Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation. Neurology 2010;74:1607&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875132</ArticleId><ArticleId IdType="pubmed">20479359</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Bolbolan K, Gefen T, et al. Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA-binding protein-43 kDa. Ann Neurol 2018;83:1096&#x2013;104</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105542</ArticleId><ArticleId IdType="pubmed">29665116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Ahmadian SS, Peterson M, et al. Asymmetric pathology in primary progressive aphasia with progranulin mutations and TDP inclusions. Neurology 2016;86:627&#x2013;36</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4762414</ArticleId><ArticleId IdType="pubmed">26791154</ArticleId></ArticleIdList></Reference><Reference><Citation>Shellikeri S, Karthikeyan V, Martino R, et al. The neuropathological signature of bulbar-onset ALS: A systematic review. Neurosci Biobehav Rev 2017;75:378&#x2013;92</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5425954</ArticleId><ArticleId IdType="pubmed">28163193</ArticleId></ArticleIdList></Reference><Reference><Citation>Bak TH, O'Donovan DG, Xuereb JH, et al. Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neuron disease-dementia-aphasia syndrome. Brain 2001;124:103&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">11133791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Oda M, Hayashi H, et al. Participation of the limbic system and its associated areas in the dementia of amyotrophic lateral sclerosis. J Neurol Sci 1994;126:62&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">7836949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara K, Araki S, Ihori N, et al. An autopsy case of frontotemporal dementia with severe dysarthria and motor neuron disease showing numerous basophilic inclusions. Neuropath 2006;26:447&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pubmed">17080724</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya K, Takahashi M, Shiotsu H, et al. Sporadic amyotrophic lateral sclerosis with circumscribed temporal atrophy: A report of an autopsy case without dementia and with ubiquitinated intraneuronal inclusions. Neuropathology 2002;22:308&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pubmed">12564772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwahara H, Tsuchiya K, Saito Y, et al. Frontotemporal lobar degeneration with motor neuron disease showing severe and circumscribed atrophy of anterior temporal lobes. J Neurol Sci 2010;297:92&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">20674934</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki Y, Mori F, Nunomura J, et al. Sporadic amyotrophic lateral sclerosis with pallido&#x2010;nigro&#x2010;luysian degeneration: A TDP&#x2010;43 immunohistochemical study. Neuropath 2010;30:149&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">19703266</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord 2000;1:293&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Fuller C, et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xe9;dirian V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuertinger S, Horwitz B, Simonyan K.. The functional connectome of speech control. PLoS Biol 2015;13:e1002209&#x2013;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4512708</ArticleId><ArticleId IdType="pubmed">26204475</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyler LK, Marslen-Wilson W.. Fronto-temporal brain systems supporting spoken language comprehension. Philos Trans R Soc B 2008;363:1037&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2494576</ArticleId><ArticleId IdType="pubmed">17827104</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassal F, Schneider F, Boutet C, et al. Combined DTI tractography and functional MRI study of the language connectome in healthy volunteers: Extensive mapping of white matter fascicles and cortical activations. PLoS One 2016;11:e0152614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4814138</ArticleId><ArticleId IdType="pubmed">27029050</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther FH, Perkell JS. A neural model of speech production and its application to studies of the role of auditory feedback in speech. Speech motor control in normal and disordered speech. Oxford, UK: Oxford University Press2004:29&#x2013;49</Citation></Reference><Reference><Citation>Strong MJ, Yang W, Strong WL, et al. Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment. Neurology 2006;66:1770&#x2013;1</Citation><ArticleIdList><ArticleId IdType="pubmed">16769962</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Yang W.. The frontotemporal syndromes of ALS. Clinicopathological correlates. J Mol Neurosci 2011;45:648&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">21809041</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, Yang Y, Kim WS, et al. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis. Acta Neuropathol Commun 2017;5:76</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5658959</ArticleId><ArticleId IdType="pubmed">29078806</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison KM, Yunusova Y, Campbell TF, et al. The diagnostic utility of patient-report and speech-language pathologists&#x2019; ratings for detecting the early onset of bulbar symptoms due to ALS. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:358&#x2013;66</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5530595</ArticleId><ArticleId IdType="pubmed">28355886</ArticleId></ArticleIdList></Reference><Reference><Citation>Green JR, Yunusova Y, Kuruvilla MS, et al. Bulbar and speech motor assessment in ALS: Challenges and future directions. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:494&#x2013;500</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833808</ArticleId><ArticleId IdType="pubmed">23898888</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova GJ, Wang J, et al. A protocol for comprehensive assessment of bulbar dysfunction in amyotrophic lateral sclerosis (ALS). J Vis Exp 2011;48</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3197394</ArticleId><ArticleId IdType="pubmed">21372794</ArticleId></ArticleIdList></Reference><Reference><Citation>DePaul R, Abbs JH, Caligiuri M, et al. Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis. Neurology 1988;38:281&#x2013;3</Citation><ArticleIdList><ArticleId IdType="pubmed">3340294</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday GM, Kiernan MC, Kril JJ, et al. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia. J Neurol Sci 2016;366:197&#x2013;201</Citation><ArticleIdList><ArticleId IdType="pubmed">27288806</ArticleId></ArticleIdList></Reference><Reference><Citation>Piao YS, Wakabayashi K, Kakita A, et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 2006;13:10&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pubmed">12580541</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y, Tan C, Toyoshima Y, et al. Sporadic amyotrophic lateral sclerosis: Widespread multisystem degeneration with TDP&#x2010;43 pathology in a patient after long&#x2010;term survival on a respirator. Neuropathology 2009;29:689&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">19170893</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwanaga K, Hayashi S, Oyake M, et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci 1997;146:139&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">9077510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills KR. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain 2003;126:2558&#x2013;66</Citation><ArticleIdList><ArticleId IdType="pubmed">12937082</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der GMM, Sage CA, Caan MWA, et al. upper and extra-motoneuron involvement in early motoneuron disease: A diffusion tensor imaging study. Brain 2011;134:1211&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pubmed">21362631</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa DM, D&#x2019;Errico E, Tortelli R, et al. Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS One 2013;8:e80748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835750</ArticleId><ArticleId IdType="pubmed">24278317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala A, Iaccarino L, Fania P, et al. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging 2019;46:1117&#x2013;31</Citation><ArticleIdList><ArticleId IdType="pubmed">30617963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, De Leon M, Wang X, et al. Relationship between clinical parameters and brain structure in sporadic amyotrophic lateral sclerosis patients according to onset type: A voxel-based morphometric study. PLoS One 2017;12:e0168424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5240978</ArticleId><ArticleId IdType="pubmed">28095425</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma G, Woo JH, Chawla S, et al. Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging. Radiology 2013;267:851&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662903</ArticleId><ArticleId IdType="pubmed">23360740</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Gong H, Li F, et al. Altered motor network functional connectivity in amyotrophic lateral sclerosis: A resting-state functional magnetic resonance imaging study. Neuroreport 2013;24:657&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">23839257</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Diekmann V, M&#xfc;ller HP, et al. Neuroimaging of multimodal sensory stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2010;81:899&#x2013;906</Citation><ArticleIdList><ArticleId IdType="pubmed">20543183</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskaran P, Shaw C, Guthrie S.. TDP-43 causes neurotoxicity and cytoskeletal dysfunction in primary cortical neurons. PLoS One 2018;13:e0196528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5963761</ArticleId><ArticleId IdType="pubmed">29787572</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt R, de Reus MA, Scholtens LH, et al. Simulating disease propagation across white matter connectome reveals anatomical substrate for neuropathology staging in amyotrophic lateral sclerosis. Neuroimage 2016;124:762&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">25869856</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Sorrentino P, Sorrentino G, et al. Neurodegeneration of brain networks in the amyotrophic lateral sclerosis-frontotemporal lobar degeneration (ALS-FTLD) continuum: Evidence from MRI and MEG studies. CNS Spectr 2018;23:378&#x2013;87</Citation><ArticleIdList><ArticleId IdType="pubmed">29076800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J. Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis. Exp Neurol 2014;262:121&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">25108067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs GG. Molecular pathology of neurodegenerative diseases: Principles and practice. J Clin Pathol 2019;72:725&#x2013;35</Citation><ArticleIdList><ArticleId IdType="pubmed">31395625</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP&#x2010;43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013;74:20&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, Veldink JH, van den Berg LH, et al. Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis. Hum Brain Mapp 2014;35:1351&#x2013;61</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6869230</ArticleId><ArticleId IdType="pubmed">23450820</ArticleId></ArticleIdList></Reference><Reference><Citation>Dum RP, Strick PL.. Spinal cord terminations of the medial wall motor areas in macaque monkeys. J Neurosci 1996;16:6513&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578918</ArticleId><ArticleId IdType="pubmed">8815929</ArticleId></ArticleIdList></Reference><Reference><Citation>Muakkassa KF, Strick PL.. Frontal lobe inputs to primate motor cortex: Evidence for four somatotopically organized &#x201c;premotor&#x201d; areas. Brain Res 1979;177:176&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">115545</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmahmann JD, Pandya DN, Wang R, et al. Association fibre pathways of the brain: Parallel observations from diffusion spectrum imaging and autoradiography. Brain 2007;130:630&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">17293361</ArticleId></ArticleIdList></Reference><Reference><Citation>Catani M, Ffytche DH.. The rises and falls of disconnection syndromes. Brain 2005;128:2224&#x2013;39</Citation><ArticleIdList><ArticleId IdType="pubmed">16141282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt SE, O&#x2019;Neal VM, et al. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol 2016;131:103&#x2013;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4699876</ArticleId><ArticleId IdType="pubmed">26650262</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E, Raaphorst J, Klein Twennaar M, et al. The cognitive profile of ALS: A systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry 2016;87:611&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">26283685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C, Murphy J, Langmore S, et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60:1094&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">12682312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringholz GM, Appel SH, Bradshaw M, et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586&#x2013;90</Citation><ArticleIdList><ArticleId IdType="pubmed">16116120</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 2018;91:e1370&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6177274</ArticleId><ArticleId IdType="pubmed">30209236</ArticleId></ArticleIdList></Reference><Reference><Citation>Massman PJ, Sims J, Cooke N, et al. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996;61:450&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1074039</ArticleId><ArticleId IdType="pubmed">8937336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichikawa H, Koyama S, Ohno H, et al. Writing errors and anosognosia in amyotrophic lateral sclerosis with dementia. Behav Neurol 2008;19:107&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5452462</ArticleId><ArticleId IdType="pubmed">18641430</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa K, Yasuda N, Fukuda M, et al. Syntactic comprehension in patients with amyotrophic lateral sclerosis. Behav Neurol 2014;2014:1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4006623</ArticleId><ArticleId IdType="pubmed">25161339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickok G, Poeppel D.. The cortical organization of speech processing. Nat Rev Neurosci 2007;8:393&#x2013;402</Citation><ArticleIdList><ArticleId IdType="pubmed">17431404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirshorn EA, Thompson-Schill SL.. Role of the left inferior frontal gyrus in covert word retrieval: Neural correlates of switching during verbal fluency. Neuropsychologia 2006;44:2547&#x2013;57</Citation><ArticleIdList><ArticleId IdType="pubmed">16725162</ArticleId></ArticleIdList></Reference><Reference><Citation>Whalen DH, Benson RR, Richardson M, et al. Differentiation of speech and nonspeech processing within primary auditory cortex. J Acoust Soc Am 2006;119:575&#x2013;81</Citation><ArticleIdList><ArticleId IdType="pubmed">16454311</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Brooks BR, Silani V.. Clinical trials in amyotrophic lateral sclerosis: Why so many negative trials and how can trials be improved? Lancet Neurol 2014;13:1127&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">25316019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman M, Cudkowicz M, Zinman L.. Enhancing clinical trials in neurodegenerative disorders: Lessons from amyotrophic lateral sclerosis. Curr Opin Neurol 2012;25:735&#x2013;42</Citation><ArticleIdList><ArticleId IdType="pubmed">23160423</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>